These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17352362)

  • 21. [Current therapy concepts in patients with multiple myeloma].
    Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
    Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
    [No Abstract]   [Full Text] [Related]  

  • 22. Allografting or autografting for myeloma.
    van Rhee F; Crowley J; Barlogie B
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17582078
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
    Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R
    Haematologica; 2003 May; 88(5):597-9. PubMed ID: 12745281
    [No Abstract]   [Full Text] [Related]  

  • 24. Autologous hematopoietic stem-cell transplantation for multiple myeloma.
    Harousseau JL; Moreau P
    N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current perspectives in the treatment of multiple myeloma - news and views].
    Knop S
    Dtsch Med Wochenschr; 2012 Mar; 137(13):636-9. PubMed ID: 22434170
    [No Abstract]   [Full Text] [Related]  

  • 26. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
    Attal M; Harousseau JL
    Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation.
    Björkstrand B; Ljungman P; Bird JM; Samson D; Brandt L; Alegre A; Auzanneau G; Bladé J; Brunet S; Carlson K
    Stem Cells; 1995 Aug; 13 Suppl 2():140-6. PubMed ID: 8520503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple myeloma.
    Kyle RA; Rajkumar SV
    N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation.
    Maggini V; Buda G; Galimberti S; Conidi E; Giuliani N; Morabito F; Genestreti G; Iacopino P; Rizzoli V; Barale R; Petrini M; Rossi AM
    Leukemia; 2007 Jan; 21(1):176-8. PubMed ID: 17066090
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of multiple myeloma].
    Terriou L; Leleu X; Yakoub-Agha I
    Bull Cancer; 2006 Jan; 93(1):101-6. PubMed ID: 16455512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive therapy in multiple myeloma.
    Harousseau JL
    Pathol Biol (Paris); 1999 Feb; 47(2):203-9. PubMed ID: 10192890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose chemotherapy in multiple myeloma.
    Goldschmidt H; Hegenbart U; Wallmeier M; Moos M; Haas R
    Leukemia; 1997 Dec; 11 Suppl 5():S27-31. PubMed ID: 9436935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two cases.
    Peterlin P; Gastinne T; Moreau P; Harousseau JL; Le Gouill S
    Transplantation; 2009 Feb; 87(4):617-8. PubMed ID: 19307803
    [No Abstract]   [Full Text] [Related]  

  • 36. The evolution and impact of therapy in multiple myeloma.
    Laubach JP; Richardson PG; Anderson KC
    Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR
    Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
    Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal timing for transplant in multiple myeloma.
    Rajkumar SV
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):684-6. PubMed ID: 22402513
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autologous stem cell transplantation in multiple myeloma - contra].
    Ludwig H
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1943. PubMed ID: 19760556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.